Press Releases

TheraVet completes first regulatory milestones for the US registration (NADA) of VISCO-VET in canine osteoarthritis

 

June 15, 2020

 

TheraVet S.A., the specialist of the osteo-articular diseases in small companion animals, announces today passing the first regulatory milestones for its product VISCO-VET in the indication of canine osteoarthritis with the U.S. Food & Drug Administration's (FDA) Center for Veterinary Medicine (CVM). Since its creation in 2019, TheraVet USA has...

 

Read more

 

 

 

 

 

 

PREVIOUS PRESS RELEASES

 

  

 

TheraVet starts its US operations in its Texas-based subsidiary

November 7, 2019

 

TheraVet S.A., the specialist of the osteo-articular diseases of small companion animals, announced today the incorporation of its Texas-based subsidiary and the launch of its activities in the United States of America. The incorporation of TheraVet USA, earlier this year...

 

Read more

 

  

 

This website uses cookies The website of TheraVet SA uses functional cookies. In case of analysing our traffic or advertising, we also place cookies that share information about your use of our site with our analytics partners, our social media and advertising partners, who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
Show details Hide details
Allow selection Allow all cookies